Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Company Profile for Optimatum Group, LLC.


Optimatum Group, LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
, founded in early 2007 by industry experts, assists clients across the US in optimizing health plan costs without raising premiums or reducing benefits, operating from offices in Atlanta Atlanta (ətlăn`tə, ăt–), city (1990 pop. 394,017), state capital and seat of Fulton co., NW Ga., on the Chattahoochee R. and Peachtree Creek, near the Appalachian foothills; inc. 1847. , Boston and New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
. Independent and vendor-neutral, Optimatum Group provides strong expertise in pharmacy pharmacy, art of compounding and dispensing drugs and medication. The term is also applied to an establishment used for such purposes. Until modern times medication was prepared and dispensed by the physician himself. In the 18th cent. , medicine, nursing, actuarial science Actuarial science applies mathematical and statistical methods to finance and insurance, particularly to risk assessment. Actuaries are professionals who are qualified in this field through examinations and experience.  and plan management. The company delivers comprehensive, immediate, visible plan savings, maintained by ongoing plan and vendor management. Company principals draw on long experience designing over 300 health plans for various types of organizations including private, family-owned, public and non-profit entities.
Company:               <
Optimatum Group, LLC
                       <

Headquarters Address:  <
330 Madison Avenue -- 6th Floor New York, NY 10017
                       <

Main Telephone:        <
212-652-8500
                       <

Type of Organization:  <
Private
                       <

Industry:              <
Finance
                       <

Key Executives:        <
CEO: David Neikrug
                       <

Public Relations       <

Contact:               <
David Neikrug
Phone:                 <
212-652-8500
Email:                 <
dneikrug@optimatumgroup.com
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Company overview
Date:Jan 4, 2008
Words:130
Previous Article:Business Activity at 53.9%; December Non-Manufacturing ISM Report On Business(R); New Orders Index at 53.5%; Employment Index at 52.1%.
Next Article:DrFirst and MEDITECH to Deliver Sophisticated Medication Reconciliation and Electronic Prescribing to Hospitals.



Related Articles
Optimata's Virtual Clones to Predict Therapy Outcome for Breast Cancer; Adriamycin, Docetaxel, Paclitaxel, Vinorelbine and Tamoxifen in Validation...
Optimata Completes Successful Breast Cancer Clinical Study: 70% Prediction Accuracy Offers New Hope for Cancer Patients.
Eli Lilly Extends Cooperation with Optimata, Developer of Virtual Patient Technology.
Optimata Virtual Patient(R) Approved as a Registered Trademark.
Optimata Granted Patent For Granulopoiesis-Modelling System, Can Optimize Cancer Drug Development With Less Toxicity.
Healthcare Industry Veterans Establish Objective Cost-Management Solution.
Health Plan Costs "Overweight" by as Much as 15%, Notes Optimatum Group.
Optimata Obtains $1.5 M for BioSimulation-Based Renewal of Discontinued Cancer Drugs.
Optimata Granted Patent for Modeling Angiogenesis and Providing Optimal Treatment.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles